SCHEMBL5175258

SCHEMBL5175258

OCCc1ccc(OCCc2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.67
NPC1 O15118 1/20 0.65
RAB9A P51151 1/20 0.65
TDP1 Q9NUW8 1/20 0.61
LTA4H P09960 3/20 0.60
EPHX2 P34913 1/20 0.59
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
ALDH1A1 P00352 1/20 0.55
RECQL P46063 1/20 0.55
HRH3 Q9Y5N1 1/20 0.51
CHRNB4 P30926 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA7 P36544 1/20 0.50
PPARG P37231 1/20 0.50
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24041796 0.91 FFAR1 (0.68) FFAR1NPC1RAB9ATDP1LTA4H
SCHEMBL19102211 0.90 ALDH1A1 (0.69) FFAR1NPC1RAB9ATDP1LTA4H
SCHEMBL24041843 0.90 ALDH1A1 (0.63) FFAR1NPC1RAB9ATDP1LTA4H
SCHEMBL4165319 0.89 FFAR1 (0.69) FFAR1TDP1LTA4HEPHX2ALDH1A1
SCHEMBL5391064 0.89 FFAR1 (0.67) FFAR1NPC1RAB9ALTA4HEPHX2
SCHEMBL8767634 0.89 KCNA3 (0.61) FFAR1TDP1LTA4HEPHX2ALDH1A1
SCHEMBL9456979 0.88 NPC1 (0.80) FFAR1NPC1RAB9ALTA4HCA12
SCHEMBL8500544 0.87 FFAR1 (0.67) FFAR1TDP1LTA4HEPHX2ALDH1A1
SCHEMBL8408714 0.86 ALDH1A1 (0.69) FFAR1NPC1RAB9ATDP1LTA4H
SCHEMBL6658231 0.86 HRH3 (0.59) FFAR1TDP1LTA4HEPHX2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102898289-B Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2014-09-03 CN disclosed
CN-102898289-B Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2014-09-03 CN disclosed
CN-102898289-A Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2013-01-30 CN disclosed
CN-102898289-A Method for synthesizing 2-(4-benzylmethoxyphenyl)ethanol medical intermediate Jiangsu defeng pharmaceutical co ltd 2013-01-30 CN disclosed
CN-100384836-C Novel cyclic amide derivative MITSUBISHI PHARMACEUTICALS INC (JP) 2008-04-30 CN disclosed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 US disclosed
CN-1426405-A Novel cyclic amide derivative MITSUBISHI PHARMACEUTICALS INC (JP) 2003-06-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S FFAR1 532/4885NPC1 1667/4885RAB9A 4254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.